If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

This can lead to inflammation and an increased risk of eosinophilic asthma. If you have severe asthma or your asthma symptoms do not improve with standard treatments, your healthcare provider may ...

First described nearly 20 years ago, eosinophilic esophagitis (EoE ... incidence and increased recognition of this disorder. Treatment options available for patients with EoE include dietary ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for severe asthma, challenges remain in managing T-helper cell type 2 (T2)-low ...

In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American ...

A Potential Therapeutic Target for Steroid Resistant Asthma,” published in the December 2024 issue of Allergy and Immunology ...

Intermediate group 2 innate lymphoid cells (ILC2s) appear to be able to get around cutting-edge asthma treatments by ...

Asthma affects more than 300 million people ... and Drug Administration and European Medicines Agency for the treatment of severe eosinophilic asthma. These biologics lower eosinophil numbers ...

Asthma & Allergy Foundation of America ... Allergy-test-based elimination diets for the treatment of eosinophilic esophagitis: A systematic review of their efficacy. J Clin Med.

Previously approved in China for severe eosinophilic asthma in adult and adolescent individuals of ... "China’s NMPA approves GSK’s Nucala for CRSwNP treatment" was originally created and published by ...

A common scenario is the patient with EoE who develops heartburn when on well-established EoE nutritional or steroid treatment ... alterations associated with eosinophilic inflammation.